WO2005092265A1 - 貼付剤 - Google Patents
貼付剤 Download PDFInfo
- Publication number
- WO2005092265A1 WO2005092265A1 PCT/JP2005/005800 JP2005005800W WO2005092265A1 WO 2005092265 A1 WO2005092265 A1 WO 2005092265A1 JP 2005005800 W JP2005005800 W JP 2005005800W WO 2005092265 A1 WO2005092265 A1 WO 2005092265A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- woven
- patch
- adhesive base
- mass
- support
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Definitions
- the present invention relates to a patch having high production efficiency and sufficient anchoring properties between an adhesive base and a support.
- Patches are usually produced by directly applying an adhesive base to a woven fabric and plastering, or by applying an adhesive base to a release film, stacking the film on the woven fabric and applying the adhesive base to the woven fabric.
- static electricity is generated in the woven fabric, causing a problem of extremely low manufacturing efficiency.
- an attempt has been made to install a process of discharging static electricity accumulated during the manufacturing process and to remove electric static electricity.
- the manufacturing cost is increased, a problem arises.
- JP-A-9-136829 describes a patch having an adhesive base layer on a support and having been subjected to an antistatic treatment.
- such a patch is subjected to an antistatic treatment to prevent the occurrence of wrinkles and the like due to static electricity when the patch is applied, and no problem of anchoring property has been reported. Therefore, there is a need for a patch which can simultaneously solve the above-mentioned problem of static electricity generation and the problem of anchoring property.
- an object of the present invention is to provide a patch which has high production efficiency and has a sufficient anchoring property between an adhesive base and a support.
- the patch of the present invention has an adhesive base on the surface of a support containing a woven or nonwoven fabric, and the adhesive base is plastered on the woven or nonwoven fabric.
- the non-woven fabric is characterized in that it has a charged voltage of -50 V to 1,400 OV in a static electricity charging test (defined in JIS L 1094).
- the support preferably contains an antistatic agent.
- the antistatic agent is preferably a surfactant.
- the surfactant may be one or more selected from the group consisting of nonionic surfactants, aionic surfactants, cationic surfactants, and amphoteric surfactants.
- the surfactant is particularly preferably an anionic surfactant.
- the woven or nonwoven fabric constituting the support is preferably made of polyethylene terephthalate.
- Anchor property between the woven fabric composed of polyethylene terephthalate adhesive base is associated only basis weight of the woven fabric (mass per unit area of fabric), basis weight of the woven fabric composed of polyethylene terephthalate 80 to 150 g / m 2 It is preferred that
- the modulus in the longitudinal direction of the woven fabric made of polyethylene terephthalate is preferably 2 to 12 NZ5 cm, and the modulus in the horizontal direction is preferably 2 to 8 NZ5 cm.
- the adhesive base contains one or more selected from rubber-based, acrylic-based and silicone-based adhesive bases, and particularly contains styrene 'isoprene' styrene block copolymer. Is preferred.
- the adhesive base of the patch contains a nonsteroidal anti-inflammatory analgesic.
- the patch of the present invention is characterized in that since the charged voltage of the woven or non-woven fabric constituting the support is adjusted to a predetermined range, the accumulation of static electricity during production is small, and the adhesive base and the support are used. Has sufficient anchoring force between Fields used as antistatic agents in general patches When a woven fabric or the like containing a surfactant is used as a support, the anchoring property between the adhesive base and the support becomes extremely poor.
- the woven or non-woven fabric is adjusted by adjusting the amount of surfactant added.
- the patch of the present invention has an adhesive base on the surface of a support containing a woven or nonwoven fabric.
- the adhesive base is plastered on a woven or nonwoven fabric, and the woven or nonwoven fabric is In the charging test by static electricity specified in L1094, it has a charged voltage of 150V to 14000V.
- the charged voltage of the woven or nonwoven fabric is preferably from -100V to -3000V, more preferably from -500V to -3000V.
- the anchoring property when the adhesive base material is plastered is reduced because static electricity causes the support to shrink and waste.
- the adhesive base remains on the skin when the adhesive base is peeled off from the support after plastering, or when the adhesive is peeled off after use (pasted on the skin).
- the charged voltage is less than 150 V, the anchoring property is deteriorated. That is, by controlling the charged voltage within the above range, it is possible to prevent anchorage between the adhesive base and the support, which can prevent the production efficiency from being lowered due to static electricity.
- the patch of the present invention uses a negatively charged support material to obtain the above-mentioned effects of production efficiency and anchoring force.
- the support can be positively charged.
- sufficient performance as a patch such as elasticity cannot be obtained.
- the woven or nonwoven fabric is impregnated with an aqueous solution containing the antistatic agent so that the antistatic agent can be directly mixed or adsorbed to the fibers of the woven or nonwoven fabric.
- the antistatic agent may be attached by drying, or an aqueous solution containing the antistatic agent may be applied to a woven or nonwoven fabric and then dried.
- the antistatic agent is preferably contained in an amount of about 0.05 to 0.6% by mass in terms of solid content based on the total mass of the support. If it is less than 0.05% by mass, the antistatic effect is insufficient, and if it exceeds 0.6% by mass, the anchoring property is poor. Needless to say, even if an antistatic agent is incorporated into the support within a vigorous range, there is no problem in safety.
- the surfactant may be any of an ionic surfactant, a cationic surfactant, a nonionic surfactant, and an amphoteric surfactant. One or more of these surfactants may be used in combination. .
- an ionic surfactant is particularly preferred in view of the relationship with the material of the support (for example, polyester is easily negatively charged).
- the ionic surfactant is not particularly limited, and examples thereof include fatty acid salts (such as sodium stearate, sodium laurate, and triethanolamine laurate), alkyl benzene sulfonates (such as sodium dodecyl benzene sulfonate), and alkyl.
- fatty acid salts such as sodium stearate, sodium laurate, and triethanolamine laurate
- alkyl benzene sulfonates such as sodium dodecyl benzene sulfonate
- alkyl such as sodium dodecyl benzene sulfonate
- the cationic surfactant is not particularly limited, and examples thereof include long-chain alkyl short-chain trialkylammonium salts (lauryltrimethylammonium chloride, myristyltrimethylammonium salt). Muchloride, palmityl trimethylammonium chloride, stearyltrimethylammonium-pam chloride, long-chain dialkyl short-chain dialkylammonium-pam salt (distearyldimethylammonium chloride), alkylpyridi-pam salt (salidylmyristylpyri) Di-dim, cetyl pyridi-dim chloride, stearyl pyridi-dim chloride, etc.), alkyl imidazoly-dim salts (1, 1-dimethyl-2-hexadecyl imidazo-dim chloride, etc.), benzyl long chain Alkyl short-chain dialkylammonium salts (eg, benzalcodium
- the nonionic surfactant is not particularly limited, and examples thereof include glycerin fatty acid ester and its alkylene glycol adduct, polyglycerin fatty acid ester and its alkylene glycol-capped product, propylene glycol fatty acid ester and its alkylene glycol addition.
- Products sorbitan fatty acid esters and their alkylene glycol adducts, sorbitol fatty acid esters and their alkylene glycol-capped products, polyalkylene glycol fatty acid esters, sucrose fatty acid esters, polyoxyalkylene alkyl ethers, glycerin alkyl ethers, polyoxyethylene alkyl esters Enyl ether, polyoxyethylene hydrogenated castor oil, lanolin mash with alkylene glycol, polyoxyalkylene alkyl co-modified silicone Over emissions, polyether-modified silicones include et be. These nonionic surfactants may be used alone or in combination of two or more.
- amphoteric surfactant is not particularly limited.
- betaine acetate-type amphoteric surfactants (betayl lauryl dimethylaminoacetate, betaine stearyl dimethylaminoacetate, betaine myristylaminoacetate, lauric amide) Propyl acetate betaine, etc.), alkylamine oxide type amphoteric surfactants (alkyl dimethylamine oxide, etc.), imidazoline type amphoteric surfactants (2-alkyl N carboxymethyl N hydroxyethyl imidazoly-m-betaine, 2 —Cocoyl N carboxymethyl N hydroxyethyl imidazolidimbetaine, 2-lauryl-1-N carboxymethyl N hydroxyethylimidazolidimbetaine, etc.), and sulfobetaine type amphoteric surfactants.
- These amphoteric surfactants may be used alone or in combination of two or more.
- a surfactant When a surfactant is applied to a support, it is necessary to provide an antistatic agent to fibers of clothes and the like.
- Known methods can be used. For example, a method in which a woven or nonwoven fabric is impregnated with an aqueous solution containing 0.05 to 2% by mass of a surfactant and dried.
- the support used in the present invention is not limited to a single-layer structure, and may have a laminated structure.
- a structure in which a plurality of woven or nonwoven fabrics made of different materials are laminated, or a structure in which a woven or nonwoven fabric is laminated with a plastic film, a metal foil, or the like may be used.
- the woven or non-woven fabric used in the present invention is obtained by knitting a fibrous material into a cloth, and any woven or non-woven fabric that can be used as a support for a patch can be used.
- a knitted fabric obtained by gathering stitches by circular knitting, warp knitting, weft knitting, or the like and processing it into a cloth shape is also included.
- Preferred examples of the woven or nonwoven fabric include a woven or nonwoven fabric obtained by combining one or more of polyester, nylon, propylene, and rayon materials. Less woven fabrics made of polyester-based polyethylene terephthalate are more preferred.
- Polyethylene terephthalate fabric having a basis weight is preferably 80 to 150 g / m 2.
- the pressure is within the range, the adhesive can be prevented from seeping through the mesh of the woven fabric when the adhesive is applied to the woven fabric, and the anchoring property between the woven fabric and the adhesive base can be maintained.
- the polyethylene terephthalate woven fabric has a modulus in the longitudinal direction (long axis direction) of 2 to 12 NZ5 cm and a modulus in the horizontal direction (short axis direction) of 2 to 8 NZ5 cm (modulus measurement method ⁇ O IS L 1018). by.).
- the modulus is lower than 2N / 5cm, the woven fabric will be stretched when the adhesive is applied, and the adhesive will permeate into the mesh, lowering the function as a patch.
- the modulus is higher than 12 NZ5 cm (vertical direction) or 8 NZ5 cm (horizontal direction), the elasticity is inferior, and it is difficult to follow the stretch of the skin when applied to a bent portion, which is not preferable.
- adhesive bases such as rubber-based, acrylic-based, silicone-based, vinyl ether-based, and vinyl ester-based adhesives that are usually used for patches can be used as appropriate.
- adhesive bases such as rubber-based, acrylic-based, silicone-based, vinyl ether-based, and vinyl ester-based adhesives that are usually used for patches can be used as appropriate.
- the rubber-based adhesive base may be any of natural rubber and synthetic rubber, for example, styrene-isoprene-styrene block copolymer, styrene-butadiene-styrene block copolymer, polyisobutylene, polybutyl ether, polyurethane , Polybutadiene, silicone rubber And the like can be preferably used.
- acrylic adhesive base examples include homopolymers of alkyl (meth) acrylates obtained from aliphatic alcohols having 4 to 18 carbon atoms and (meth) acrylic acid, and Z or the above ( Copolymers of alkyl (meth) acrylates with other functional monomers are preferred.
- (Meth) acrylates include butyl acrylate, isobutyl acrylate, hexyl acrylate, octyl acrylate, 2-ethylhexyl acrylate, decyl acrylate, isodecyl acrylate, lauryl acrylate, acrylic acid Examples include stearyl, methyl methacrylate, ethyl methacrylate, butyl methacrylate, isobutyl methacrylate, diethylhexyl methacrylate, lauryl methacrylate, stearyl methacrylate, and methoxyethyl acrylate.
- an aionic surfactant when used as an antistatic agent, it is more preferable to use a rubber-based adhesive base among the above-mentioned adhesive bases, and it is more preferable to use a styrene-isoprene-styrene block copolymer. It is more preferable to use an adhesive base selected from polyisobutylene and styrene-butadiene-styrene block copolymer.
- the patch of the present invention may contain components other than those described above as long as the object of the present invention is not impaired.
- the adhesive base may be styrene-isoprene-styrene block copolymer, polyisobutylene, styrene-butadiene-styrene block copolymer, synthetic aluminum silicate, zinc stearate, aluminum hydroxide, stearin Magnesium acid, sodium stearate, polyisobutylene, petroleum resin, rosin resin, liquid paraffin, crotamiton, getyl sebacate, diisopropyl adipate, propylene glycol monocaprylate, propylene glycol dicaprylate, 1-menthol Propyl gallate, di-Tert-butylhydroxytoluene, 4-Tert-butyl-4'-methoxydibenzoylmethane, and the like.
- the adhesive base may contain various drugs depending on the purpose. Drugs include anti-inflammatory, cardiotonic, anesthetic, antihypertensive, hormonal, antidiabetic, antiarrhythmic, antihistamine, antiparkinson, peripheral vasodilator, coronary vasodilator, vasoconstrictor Drugs, drugs for hemostasis, drugs for nerve nerves and the like.
- patches containing anti-inflammatory drugs are often used locally, that is, for joints such as elbows and knees. Is preferably one that withstands expansion and contraction.
- the patch of the present invention has an excellent anchoring property between the support and the adhesive base, and also has a good sticking property when the patch is used. Suitable when a non-steroidal anti-inflammatory analgesic is compounded.
- the nonsteroidal anti-inflammatory analgesic is not particularly limited, and examples thereof include ketoprofen, diclofenac, suprofen, piroxicam, indomethacin, flurbiprofen, fuerbinac, oral xoprofen, and the like, and salts thereof.
- Polyethylene terephthalate woven fabric (100 g / m 2 in weight, vertical modulus 10 NZ5 cm, horizontal modulus 5 NZ5 cm) and anionic surfactant (Derektor KC: manufactured by Meisei Chemical Industry Co., Ltd.) are calculated to be approximately 0. 1% by mass adsorbed, this is the charged voltage measured by the charging test specified by 2000VCFIS L 1094, the value when tested in an environment of 20 ° C and 40% RH using cotton as a friction cloth. A support having a charged voltage was produced.
- styrene-isoprene-styrene block copolymer (SIS5200 P: manufactured by JSR Corporation), 10 parts by mass of polyisobutylene (L-100: manufactured by ExxonMobil), petroleum resin (Alcon P-70: Arakawa Chemical Industry Co., Ltd.) 19 parts by mass, liquid paraffin (Cristol N-352: Etsuso Oil Co., Ltd.) 45 parts by mass, synthetic aluminum silicate 2 parts by mass, crotamiton 3 parts by mass, ketoprofen
- An adhesive base having a strength of 2 parts by mass and a force of 3 parts by weight of 1-menthol was plastered by a hot melt method and cut into a desired size to obtain a tape.
- Polyurethane terephthalate woven fabric 80 g / m 2 , modulus of length 4N / 5cm, modulus of width 3NZ5cm
- a surfactant Nice Pole PR-99: Nika Chemical Co., Ltd.
- This is the charged voltage measured by the chargeability test specified by 1000VCFIS L 1094, using cotton as a friction cloth at 20 ° C and 40% RH. (A value at the time of the test).
- a styrene-isoprene-styrene block copolymer (Quintac 3421: 25 parts by mass of Nippon Zeon Co., Ltd.), 10 parts by mass of polyisobutylene (L-100: manufactured by Exxon Mobil Corporation), 25 parts by mass of petroleum resin (Alcon P-70: manufactured by Arakawa Chemical Industry Co., Ltd.) Fluid No.
- ⁇ Raffine (Cristol N-352: manufactured by Etsuso Oil Co., Ltd.) 30 parts by mass, 2 parts by mass of zinc stearate, 3 parts by mass of crotamiton, 2 parts by mass of ketoprofen, and 3 parts by mass of menthol It was plastered by a hot melt method and cut into a desired size to obtain a tape.
- Polyethylene terephthalate woven fabric (basis weight 140 g / m 2 , vertical modulus 12 NZ5 cm, horizontal modulus 7 NZ5 cm) and anionic surfactant (Derektor KC: manufactured by Meisei Chemical Industry Co., Ltd.) are converted to a solid content of approx. It is a charged voltage measured by an electrification test specified by 3900VCFIS L1094 after adsorbing at 05 mass%, and a value when tested in an environment of 20 ° C and a humidity of 40% RH using cotton as a friction cloth. A support having a charged voltage was produced.
- a styrene-isoprene-styrene block copolymer (SIS520P: manufactured by JSR Corporation), 20 parts by mass of polyisobutylene (L100: manufactured by ExxonMobil), a rosin-based resin ( KE-311: Arakawa Chemical Industry Co., Ltd.) 15 parts by mass, liquid paraffin (Cristol N-352: Etsuso Oil Co., Ltd.) 39 parts by mass, synthetic aluminum silicate 2 parts by mass, crotamiton 3 parts by mass, ketoprofen 2 parts by mass Parts and 3 parts by weight of menthol were plastered by a hot melt method and cut into a desired size to obtain a tape.
- SIS520P styrene-isoprene-styrene block copolymer
- L100 manufactured by ExxonMobil
- a rosin-based resin ( KE-311: Arakawa Chemical Industry Co., Ltd.) 15 parts by mass
- Non-ionic surfactant (Nice Pole EF-26: Nika Chemical Co., Ltd.) is added to polyethylene terephthalate woven fabric (basis weight 120 g / m 2 , vertical modulus 8 NZ 5 cm, horizontal modulus 4 NZ 5 cm) to convert the total mass to solid content. It is a charged voltage measured by the chargeability test specified by 3000VCFIS L1094 when adsorbed by about 0.1% by mass, when tested in an environment of 20 ° C and humidity of 40% RH using cotton as a friction cloth. A support having a charged voltage of (a) was prepared.
- styrene-isoprene-styrene block copolymer (Quintak 3570C: manufactured by Zeon Corporation), 10 parts by mass of polyisobutylene (OPanol B 10SF: manufactured by BASF), rosin-based resin (Stevelite ester: 25 parts by mass, manufactured by Ridani FineTech Co., Ltd.), 30 parts by mass of liquid paraffin (Cristol N-352: manufactured by Etsuso Oil Co., Ltd.), 2 parts by mass of synthetic aluminum silicate, 5 parts by mass of diisopropyl adipate Part, ketoprofen 2 quality
- a part of the adhesive base and 3 parts by weight of 1-menthol were plastered by a hot melt method and cut into a desired size to obtain a tape.
- a polyethylene terephthalate woven fabric (having a basis weight of 100 g / m 2 , a vertical modulus of 10 N / 5 cm, and a horizontal modulus of 5 NZ5 cm) was used as a support.
- the charged voltage of the support is-6000 V (This is the charged voltage measured by the charging test specified in JIS L 1094.When the test is performed in an environment of 20 ° C and a humidity of 40% RH using cotton as a friction cloth. Value).
- styrene-isoprene-styrene block copolymer (SIS5200P: manufactured by JSR Corporation), 10 parts by mass of polyisobutylene (L-100: manufactured by ExxonMobil), petroleum resin (Alcon P-70: Rough) 11 Chemicals Co., Ltd.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Adhesive Tapes (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006511570A JP4664281B2 (ja) | 2004-03-29 | 2005-03-29 | 貼付剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-096535 | 2004-03-29 | ||
JP2004096535 | 2004-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005092265A1 true WO2005092265A1 (ja) | 2005-10-06 |
Family
ID=35055959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/005800 WO2005092265A1 (ja) | 2004-03-29 | 2005-03-29 | 貼付剤 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4664281B2 (ja) |
TW (1) | TW200602007A (ja) |
WO (1) | WO2005092265A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8382729B2 (en) | 2008-01-31 | 2013-02-26 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
US8455376B2 (en) | 2006-08-04 | 2013-06-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2750369C (en) * | 2008-12-16 | 2016-04-05 | Hisamitsu Pharmaceutical Co., Inc. | Pressure-sensitive adhesive tape package |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0683033U (ja) * | 1993-05-25 | 1994-11-29 | 積水化学工業株式会社 | 粘着テープ |
JPH0947469A (ja) * | 1995-08-08 | 1997-02-18 | Sekisui Chem Co Ltd | 帯電防止性救急絆創膏 |
JPH09136829A (ja) * | 1995-11-15 | 1997-05-27 | Sekisui Chem Co Ltd | 貼付剤 |
JP2003002826A (ja) * | 2001-06-20 | 2003-01-08 | Nippon Hanekku:Kk | マイナスイオン発生外用貼付剤 |
-
2005
- 2005-03-29 JP JP2006511570A patent/JP4664281B2/ja active Active
- 2005-03-29 TW TW094109842A patent/TW200602007A/zh unknown
- 2005-03-29 WO PCT/JP2005/005800 patent/WO2005092265A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0683033U (ja) * | 1993-05-25 | 1994-11-29 | 積水化学工業株式会社 | 粘着テープ |
JPH0947469A (ja) * | 1995-08-08 | 1997-02-18 | Sekisui Chem Co Ltd | 帯電防止性救急絆創膏 |
JPH09136829A (ja) * | 1995-11-15 | 1997-05-27 | Sekisui Chem Co Ltd | 貼付剤 |
JP2003002826A (ja) * | 2001-06-20 | 2003-01-08 | Nippon Hanekku:Kk | マイナスイオン発生外用貼付剤 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8455376B2 (en) | 2006-08-04 | 2013-06-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8809615B2 (en) | 2006-08-04 | 2014-08-19 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US9233184B2 (en) | 2006-08-04 | 2016-01-12 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8382729B2 (en) | 2008-01-31 | 2013-02-26 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005092265A1 (ja) | 2008-02-07 |
TW200602007A (en) | 2006-01-16 |
JP4664281B2 (ja) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060193900A1 (en) | Pressure sensitive adhesive and patch | |
EP2252667B1 (en) | Fluid absorbent adhesive articles | |
KR20090009235A (ko) | 탐스로신 함유 경피흡수형 제재 | |
JP4660858B2 (ja) | 経皮吸収型製剤 | |
US9656441B2 (en) | Transdermal patch | |
KR20010072666A (ko) | 산성기를 갖는 비스테로이드성 항류머티스제를 함유하는국소용 패치 | |
KR20060108511A (ko) | 접착 제품 | |
JP5089933B2 (ja) | 含水系粘着剤組成物及びそれを用いた貼付剤 | |
WO2001093839A1 (fr) | Element pour l'application d'une pommade et tampon a pommade dans lequel ledit element est utilise | |
JP2021006565A (ja) | 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤 | |
WO2005092265A1 (ja) | 貼付剤 | |
JP7257410B2 (ja) | 含水系貼付剤 | |
JP2007015963A (ja) | 貼付剤 | |
JP6613251B2 (ja) | 医療用途に使用される改善された接着剤 | |
JP6832287B2 (ja) | 2層の接着層を含むオーバーテープを用いる経皮治療システム | |
JP4428903B2 (ja) | 非吸蔵性裏打ち層を有する吸蔵性経皮治療系 | |
JP2014087704A (ja) | 貼付剤及び貼付製剤 | |
JP6528154B2 (ja) | ビソプロロール含有貼付製剤 | |
JP4851671B2 (ja) | トラニラスト経皮吸収貼付剤およびその製造方法 | |
JPH1067652A (ja) | 貼付剤用支持体及びそれを用いた貼付剤 | |
TWI773967B (zh) | 貼附劑 | |
JPH0769869A (ja) | ブニトロロール含有貼付製剤 | |
JP2000319123A (ja) | シート状パック剤 | |
JP2004075537A (ja) | エストラジオール含有貼付剤 | |
JPH10101527A (ja) | 角栓除去用粘着シート |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006511570 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |